Article Figures & Data
Figures
- Figure 1.
Time to Hospitalization for Heart Failure in the SAVOR Trial
CVD/HF post hoc composite: 5.9% vs 5.0%; HR, 1.15; P = .039. Black vertical lines indicate landmark analysis at 12 months: 1.7% vs 1.5%; HR, 1.09; P = .51; time-varying interaction, P = .017.
Adapted from Scirica BM et al. Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial. Circulation. 2014;130:1579–1588. With permission from American Heart Association, Inc.
Tables
Tools
Table of contents
Cited By...
- No citing articles found.